MYC and neoplasm: The authors proposed that tumor epithelial cells favor the downregulation of p62 in CAFs leading to reduced mTORC1 activity and c-Myc expression, impaired metabolic detoxification, and release of IL-6 with subsequent promotion of epithelial tumor growth and invasion[91].